1. Home
  2. Southern Africa
  3. South Africa

Concerns raised about Nevirapine report

A media report saying research had found that pregnant women using the anti-AIDS drug, Nevirapine, could develop resistance to future use of HIV/AIDS drugs, has raised concern in South Africa. The findings were presented at the 11th Annual Retrovirus Conference, held recently in San Francisco in the US. According to BuaNews, a local news service, Nevirapine was currently being used in the government's national programme for the prevention of mother-to-child transmission (PMTCT) of HIV at 18 pilot sites. Health Minister Manto Tshabalala-Msimang responded by saying she had referred these concerns to the Medicines Control Council (MCC) for investigation as soon as possible, and would be advised of their findings.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join